IBDEI20U ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33872,1,3,0)
 ;;=3^Hyperaldosteronism,Other
 ;;^UTILITY(U,$J,358.3,33872,1,4,0)
 ;;=4^E26.89
 ;;^UTILITY(U,$J,358.3,33872,2)
 ;;=^5002737
 ;;^UTILITY(U,$J,358.3,33873,0)
 ;;=N25.81^^154^1708^27
 ;;^UTILITY(U,$J,358.3,33873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33873,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,33873,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,33873,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,33874,0)
 ;;=E22.2^^154^1708^26
 ;;^UTILITY(U,$J,358.3,33874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33874,1,3,0)
 ;;=3^SIADH
 ;;^UTILITY(U,$J,358.3,33874,1,4,0)
 ;;=4^E22.2
 ;;^UTILITY(U,$J,358.3,33874,2)
 ;;=^5002718
 ;;^UTILITY(U,$J,358.3,33875,0)
 ;;=D63.1^^154^1709^1
 ;;^UTILITY(U,$J,358.3,33875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33875,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,33875,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,33875,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,33876,0)
 ;;=I12.0^^154^1709^9
 ;;^UTILITY(U,$J,358.3,33876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33876,1,3,0)
 ;;=3^HTN w/ CKD w/ Stage 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,33876,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,33876,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,33877,0)
 ;;=I95.1^^154^1709^10
 ;;^UTILITY(U,$J,358.3,33877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33877,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,33877,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,33877,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,33878,0)
 ;;=I95.89^^154^1709^11
 ;;^UTILITY(U,$J,358.3,33878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33878,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,33878,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,33878,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,33879,0)
 ;;=N17.9^^154^1709^12
 ;;^UTILITY(U,$J,358.3,33879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33879,1,3,0)
 ;;=3^Kidney Failure,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,33879,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,33879,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,33880,0)
 ;;=N18.5^^154^1709^3
 ;;^UTILITY(U,$J,358.3,33880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33880,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,33880,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,33880,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,33881,0)
 ;;=N18.9^^154^1709^4
 ;;^UTILITY(U,$J,358.3,33881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33881,1,3,0)
 ;;=3^Chronic Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33881,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,33881,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,33882,0)
 ;;=N39.0^^154^1709^14
 ;;^UTILITY(U,$J,358.3,33882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33882,1,3,0)
 ;;=3^Urinary Tract Infection,Unspec Site
 ;;^UTILITY(U,$J,358.3,33882,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,33882,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,33883,0)
 ;;=R31.9^^154^1709^8
 ;;^UTILITY(U,$J,358.3,33883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33883,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,33883,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,33883,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,33884,0)
 ;;=R31.0^^154^1709^7
 ;;^UTILITY(U,$J,358.3,33884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33884,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,33884,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,33884,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,33885,0)
 ;;=R60.9^^154^1709^6
 ;;^UTILITY(U,$J,358.3,33885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33885,1,3,0)
 ;;=3^Edema,Unspec
 ;;^UTILITY(U,$J,358.3,33885,1,4,0)
 ;;=4^R60.9
